Abiopharma

New Form 3/A - VCI Global Ltd <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001213900-26-046467 <b>Size:</b> 3 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001213900-26-046466 <b>Size:</b> 2 MB

Otitoju Kolawole A. 🟢 acquired 257.0K shares (2 derivative) of 908 Devices Inc. (MASS) at $7.26 ($1.1M) Transaction Date: Apr 21, 2026 | Filing ID: 000004

(30% Negative) BCB BANCORP INC (BCBP) Reports Q2 2026 Financial Results

New Form ARS - Consolidated Water Co. Ltd. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001104659-26-046534 <b>Size:</b> 2 MB

Johnson & Johnson - IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting

New Form DEFA14A - GARMIN LTD <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001308179-26-000319 <b>Size:</b> 9 MB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001918704-26-010482 <b>Size:</b> 494 KB

(99% Neutral) PROSPERITY BANCSHARES INC (PB) Announces Business Combination

American Oncology Network to Participate in 11 Sessions at 2026 Community Oncology Alliance Annual Conference

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)

New Form DEFA14A - Consolidated Water Co. Ltd. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001104659-26-046533 <b>Size:</b> 852 KB